Celladon Corporation , a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced that it will host an Investor and Analyst Day on Tuesday, May 6, 2014 at 8:00 a.m. in New York City.
http://ift.tt/1hOd6G4
http://ift.tt/1hOd6G4
No comments:
Post a Comment